INVOLVEMENT OF ORGANIC ANION TRANSPORTING POLYPEPTIDES IN THE TRANSPORT OF TROGLITAZONE SULFATE: IMPLICATIONS FOR UNDERSTANDING TROGLITAZONE HEPATOTOXICITY
- 20 February 2004
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 32 (3), 291-294
- https://doi.org/10.1124/dmd.32.3.291
Abstract
Troglitazone is a thiazolidinedione insulin sensitizer drug that is metabolized mainly to a sulfate conjugate (M-1) in humans. It was reported to cause hepatotoxicity, although the cause has not been fully clarified. The objective of this study was to identify whether organic anion transporting polypeptide (OATP) transporters expressed at the basolateral membrane of human hepatocytes participate in troglitazone-associated hepatotoxicity. When OATP-B, OATP-C, or OATP8 was expressed in Xenopus oocytes, the transporter-mediated uptake into oocytes of troglitazone sulfate conjugate and the inhibitory effects of thiazolidinediones and the metabolites of troglitazone on estrone-3-sulfate transport were measured. M-1 was transported well by OATP-C but was not transported by OATP-B. OATP8 showed weak, but not statistically significant, transport of M-1. M-1 exhibited a strong inhibitory effect on estrone-3-sulfate transport by OATP-C and OATP8, suggesting a higher affinity than other thiazolidinediones and the metabolites of troglitazone, glucuronide conjugate and quinone metabolite. In conclusion, the sulfate conjugate of troglitazone has a higher affinity for OATPs than troglitazone itself or other metabolites. Since OATP transporters are important in the hepatic handling of bile acids, bilirubin, and other endogenous anionic compounds, M-1 may disturb the hepatic influx and efflux transport of these endogenous molecules across the basolateral membranes. Moreover, OATP-C may be involved in the hepatic toxicity of troglitazone through the inhibitory action of M-1.Keywords
This publication has 15 references indexed in Scilit:
- Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [d-Ala2, d-Leu5]-enkephalinJournal of Pharmacy and Pharmacology, 2003
- A Naturally Occurring Mutation in the SLC21A6Gene Causing Impaired Membrane Localization of the Hepatocyte Uptake TransporterPublished by Elsevier BV ,2002
- The superfamily of organic anion transporting polypeptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2002
- Genetic Polymorphisms of Human Organic Anion Transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): Allele Frequencies in the Japanese Population and Functional AnalysisJournal of Pharmacology and Experimental Therapeutics, 2002
- Cholestatic Potential of Troglitazone as a Possible Factor Contributing to Troglitazone-Induced Hepatotoxicity: In Vivo and in Vitro Interaction at the Canalicular Bile Salt Export Pump (Bsep) in the RatMolecular Pharmacology, 2001
- Intestinal absorption and excretion of troglitazone sulphate, a major biliary metabolite of troglitazoneXenobiotica, 2000
- Clinical Pharmacokinetics of TroglitazoneClinical Pharmacokinetics, 1999
- Pharmacokinetics of troglitazone, a PPAR-γ agonist, in patients with hepatic insufficiencyEuropean Journal of Clinical Pharmacology, 1998
- Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with TroglitazoneAnnals of Internal Medicine, 1998
- Lack of Effect of Type II Diabetes on the Pharmacokinetics of Troglitazone in a Multiple-Dose StudyThe Journal of Clinical Pharmacology, 1997